The etiology of benign prostatic hypertrophy

Medical Hypotheses

Volumn 50, Issue 1, 1998, Pages 61-65

  Roper, W G ^a  

^a NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN;

BACTERIAL COLONIZATION; EMBRYOLOGY; HUMAN; HYPOTHESIS; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SHORT SURVEY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0031973869     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90179-7     Document Type: Article

References (22)

1. Walsh P, Retic A, Stamey T, Vaughan E. Campbells Urology, 6th edn. Philadelphia: WB Saunders, 1987: 231-239.
2. Sikes R A, Thomsen S, Petrow V et al. Inhibition of experimentally induced mouse prostatic hyperplasia. Biol Reproduction 1990; 43(2): 353-362.
3. De Groot L J. Endocrinology, 2nd edn, Vol. 3. New York: Grune and Stratton, 1979: 2155.
4. Coffey D S, Walsh P C. Clinical and experimental studies of BPH. Urol Clin N Am 1990; 17(3): 461-475.
5. Bosch R J. Pathogenesis of benign prostatic hyperplasia. Eur Urol 1991; 20(suppl. 1): 27-30.
6. Partin A W, Oesterling J E, Epstein J I et al. Influence of age and endocrine factors on the volume of BPH. J Urol 1991; 145(2): 405-409.
7. Desgrandchamps F, Tatoud R, Cussenot O et al. Prostatic growth factors and BPH: current knowledge and perspectives. Progres En Urologie 1992; 2(6): 1031-1044.
8. Story M T. Polypeptide modulators of prostatic growth and development. Cancer Surveys 1991; 11: 123-146.
9. McNeal J. Pathology of BPH: insight into etiology. Urol Clin N Am 1990; 17(3): 477-486.
10. Imperato-McGinley J, Sanchez R S, Spencer J R et al. Comparison of the effects of the 5-alpha-reductase inhibitor finasteride and the anti-androgen flutamide on prostate and genital differentiation. Endocrinology 1992; 131(3): 1149-1156.
11. Isaacs J T. Etiology of BPH. Eur Urol 1994; 25(suppl. 1): 6-9.
12. Walsh P, Retic A, Stamey T, Vaughan E. Campbells Urology, 6th edn. Philadelphia: Saunders, 1987: 808, 227, 811.
13. Gleason P E, Jones J A, Regan J S et al. Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol 1993; 149(6): 1586-1592.
14. Sternberg S S. Histology for Pathologists. New York: Raven Press, 1992: 757.
15. Blandy J, Lytton B. The Prostate. London: Butterworths, 1986: 7-9, 34.
16. Grays Anatomy, 37th edn. Edinburgh: Churchill Livingstone, 1989: 1422.
17. Gilvernet A Jr, Vijande JM, Alvarez R. Ejaculation in men: a dynamic endorectal ultrasonographical study. Br J Urol 1994; 73(4): 442.
18. Walter J B, Israil M S. General Pathology, 6th edn. Edinburgh: Churchill Livingstone, 1987.
19. Baron S. Medical Microbiology, 3rd edn. Menlo Park, CA: Addison-Wesley, 1991: 142.
20. Cockett A T, di Sant' Agnese P A, Gopinath P et al. Relationship of neuroendocrine cells of prostate and seretonin to BPH. Urology 1993; 42(5): 512-519.
21. Stamm W E, Turk M. Urinary tract infection and pylonephritis. In: Harrisons Textbook of Medicine, Vol. 1, 12th edn. New York: McGraw-Hill, 1991: Genetic Factors, 540.
22. Sheinfeld J, Schaeffer A J, Cordon-Cardo C et al. Association of the Lewis blood-group phenotype with recurrent UTI in women. N Engl J Med 1989; 320(12): 773.